A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Clinical trial NCT04895696 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04895696
- Sponsor
- Beeline Medicines Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2026-06-12
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.